Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement ...
Vera Therapeutics (VERA) Expected to Announce Quarterly Earnings on Wednesday
Vera Therapeutics (NASDAQ:VERA – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, March 19th. Analysts expect Vera Therapeutics to post earnings of ...
Vera Therapeutics: Does The Earlier Otsuka Launch Harm Its Prospects Much?
Vera stock dropped after Otsuka announced plans for accelerated approval of sibeprenlimab. Learn why VERA stock is a Hold.
ETF Daily News5d
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $64.67 Consensus Price Target from Brokerages
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports.
Business Insider8d
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement awards consisting ...
Vera Therapeutics (VERA) Gets a Buy from TD Cowen
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Vera Therapeutics (VERA – Research Report), with a price target ...
Mena FN9d
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(MENAFN- GlobeNewsWire - Nasdaq) BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee ...